Journal article

Harnessing the immune system via Fc gamma R function in immune therapy: a pathway to next-gen mAbs

Alicia M Chenoweth, Bruce D Wines, Jessica C Anania, P Hogarth

Immunology and Cell Biology | WILEY | Published : 2020


The human fragment crystallizable (Fc)γ receptor (R) interacts with antigen-complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host-protective effector functions that are key to the normal physiology of immune resistance to pathogens. More than 100 therapeutic monoclonal antibodies (mAbs) are approved or in late stage clinical trials, many of which harness the potent FcγR-mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody-dependent killing or phagocytosis but is also true to some degree for the mAbs that neutralize or remove small macromolecules such as cytokines or ot..

View full abstract

University of Melbourne Researchers